by Newborn calf serum is derived from blood extracted from newborn calves less than 20 days old. It is commonly used in cell culture media as a supplement for propagating and maintaining the growth of various cell types due to its richness in growth factors, attachment and nutrient factors. Newborn calf serum is a rich source of nutrients that enhance cell attachment and growth for various cell types including stem cells, primary cells and immortalized cell lines. The Global Newborn Calf Serum Market Size is estimated to be valued at US$ 730 million in 2023 and is expected to exhibit a CAGR of 9.9% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The rising demand from biotechnology and stem cell research is the major trend propelling the growth of the newborn calf serum market. Newborn calf serum is considered the gold standard in cell culture media and is majorly used as a cell culture supplement in stem cell therapeutics development, bioprocessing, vaccine production and biomedical research. According to a report by the International Society for Stem Cell Research, over 700 clinical trials using stem cell therapeutics were underway globally in 2020, indicating rising interest from pharmaceutical companies towards stem cell-based therapies. This is expected to significantly drive the consumption of newborn calf serum for stem cell bioprocessing and research activities. Furthermore, growing R&D in regenerative medicines and rollout of advanced stem cell clinical trials for various diseases including COVID-19 is further augmenting the demand for newborn calf serum.
SWOT Analysis
Strength: Newborn Calf Serum is ideal for cellular growth and recovery. It is widely used in biotechnology research and applications.
Weakness: Supply challenges as newborn calf serum is derived from live calves. Ethical issues surrounding animal welfare in its production.
Opportunity: Emerging markets in Asia and Latin America expanding research capabilities is opening new revenue avenues.
Threats: Alternatives like chemically defined serum-free media are gaining traction to address ethical and supply concerns of newborn calf serum. Stringent regulations can affect production.
Key Takeaways
The global Newborn Calf Serum market is expected to witness high growth.
Regional analysis: North America currently dominates the market and is expected to continue its dominance over the forecast period owing to strong research infrastructure and presence of leading life science players. The Asia Pacific region is expected to be the fastest growing market due to increasing investments in research and advancing biopharma industries in countries like China and India.
Key players operating in the Newborn Calf Serum market are Thermo Fisher Scientific, Atlanta Biologicals, Life Technologies, Sigma-Aldrich, Biowest, Gemini, Bovogen, Moregate Biotech, VWR, Internegocios, Corning, and PAN-Biotech.
*Note:
1.Source: Coherent Market Insights, Public sources, Desk research
2.We have leveraged AI tools to mine information and compile it
